APA (7th ed.) Citation

MA, S., Z, H., E, C., C, P., CS, H., JR, F., . . . HM, N. (2026). Early Echocardiographic and Serum Biomarkers Predict Thrombotic Microangiopathy, Endotheliopathy, and Survival After Pediatric Hematopoietic Stem Cell Transplant. Transplantation and cellular therapy, 32(3), 306.e1-306.e13. https://doi.org/10.1016/j.jtct.2025.11.024

Chicago Style (17th ed.) Citation

MA, Smith, Hutchinson Z, Colglazier E, Parker C, Higham CS, Fineman JR, Zinter MS, Dvorak CC, and Nawaytou HM. "Early Echocardiographic and Serum Biomarkers Predict Thrombotic Microangiopathy, Endotheliopathy, and Survival After Pediatric Hematopoietic Stem Cell Transplant." Transplantation and Cellular Therapy 32, no. 3 (2026): 306.e1-306.e13. https://doi.org/10.1016/j.jtct.2025.11.024.

MLA (9th ed.) Citation

MA, Smith, et al. "Early Echocardiographic and Serum Biomarkers Predict Thrombotic Microangiopathy, Endotheliopathy, and Survival After Pediatric Hematopoietic Stem Cell Transplant." Transplantation and Cellular Therapy, vol. 32, no. 3, 2026, pp. 306.e1-306.e13, https://doi.org/10.1016/j.jtct.2025.11.024.